![](https://biospectal.com/wp-content/uploads/2024/07/Digital-AI-Heart-300x197.png)
Connected Mobile Health Apps: Transforming Public Health in Low and Middle-Income Countries
The landscape of public health is undergoing a significant transformation, particularly in low and middle-income countries (LMICs). One of the driving forces behind this change is the widespread adoption of connected mobile health (mHealth) apps, which are revolutionizing healthcare delivery
![](https://biospectal.com/wp-content/uploads/2024/07/Digital-AI-Heart-300x197.png)
AI’s Transformative Impact on Vital Signs and Blood Pressure Monitoring
The advent of Artificial Intelligence (AI) is poised to revolutionize the field of healthcare, particularly in the realm of vital signs and blood pressure (BP) monitoring. Traditional methods, while effective, are often limited by their reliance on sporadic measurements and the need for specialized
![](https://biospectal.com/wp-content/uploads/2023/11/how-gondola-works-300x169.jpg)
The Silent Threat: Why Blood Pressure Management Becomes Essential With Age
Blood pressure, the force exerted by blood against your artery walls, plays a vital role in delivering oxygen and nutrients throughout the body. As we age, however, this vital function can become a silent threat. Uncontrolled high blood pressure, often
![RTS Swiss TV Introduces OptiBP](https://biospectal.com/wp-content/uploads/2024/02/RTS-Feature-Intro-e1713497828245-300x154.jpg)
Biospectal OptiBP™ Blood Pressure App Launches in Switzerland, Featured on National TV Channel RTS
Biospectal OptiBP™ has launched and is available on the Google Play Store in Switzerland. OptiBP was Featured on National TV Channel RTS and reviewed the perspectives of the patient, the doctor, and the entrrepreneurs at Biospectal.
![](https://biospectal.com/wp-content/uploads/2024/01/mockuuups-man-typing-on-a-iphone-14-pro-mockup-in-the-office-scaled-e1706038329569-300x110.jpeg)
Biospectal OptiBP Receives First-Ever CE Mark for a Smartphone Blood Pressure Monitoring App
We’re thrilled to announce that have we received European CE MDR Class IIa medical device certification for its optical fingertip blood pressure monitoring app, OptiBP™! This major milestone in our mission to enable ease of access and actionability for remote
![](https://biospectal.com/wp-content/uploads/2023/07/MIT-Square600-e1706321176988-300x179.png)
MIT’s Health in Fragile Contexts Challenge Recognizes Biospectal’s Global Health Kenya Initiative
One of Biospectal’s core areas of emphasis and a key part of our mission is to enable better health management and longer, healthier lives by leveraging commonly available computing devices for remote monitoring and improved engagement with doctors. By using
![Global health Tanzania study published in Nature's NPJ Digital Medicine](https://biospectal.com/wp-content/uploads/2024/01/Tanzania-Clinical-Study-1-300x200.jpg)
Nature’s NPJ Digital Medicine publishes positive results from a global health study evaluating OptiBP™ mobile blood pressure monitoring app in low-resource urban and rural settings
We’re excited to announce that Nature’s NPJ Digital Medicine has published the first independent research and validation study showing the potential of the OptiBP mobile app to manage high blood pressure. In line with our mission to make easy to
![](https://biospectal.com/wp-content/uploads/2024/01/Harvard-SEAS-Paulson-Logo-300x86.jpg)
Harvard’s John A. Paulson School of Engineering invites Biospectal to Spend an Evening Sharing Insights into Medical Innovation and Public Good
We had a great time returning to our old stomping grounds in Cambridge to share tales as alumni from the startup world and learnings from our journey to bring technology to the world to benefit society. Students recently learned all
![Amref Logo](https://biospectal.com/wp-content/uploads/2024/01/Amref-Logo-Color600-300x177.png)
Biospectal Partners with Amref Health Africa to Extend Global Access to Blood Pressure Management
Biospectal and Amref Health Africa, the largest health NGO in Africa, today announced the launch of a Mobile Remote Patient Monitoring (MRPM) hypertension management pilot program in Kibera (Nairobi), Kenya, the largest informal settlement in Africa. The first-of-its-kind partnership will
![](https://biospectal.com/wp-content/uploads/2022/06/4zfwcKLJrEeiHh8vysqGNCtX.png)
Biospectal Selected as Top 3 Innovation Award Finalist for Swiss Medtech Day on June 14, 2022
We’re at it again! Come visit us in Lausanne, Switzerland on 16 May where Biospectal will present as one of three top innovators by Swiss Healthcare Startups. We’ll present to a select group at SHS Healthcare Madness with Antoine Hubert